Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen

Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Telecommunication Services
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Telmisartan/amlodipin (atc-code Nach Who: C09db04)
Closing Date31 Dec 2024
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Distigmin (atc-code Nach Who: N07aa03)
Closing Date31 Oct 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Aerospace and Defence
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Pamidronsäure (atc-code Nach Who: M05ba03)
Closing Date31 Jan 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Germany-erfurt: Pharmaceutical Products
Closing Date31 May 2025
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Natalizumab (atc-code Nach Who: L04aa23)
Closing Date31 Mar 2025
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient peginterferon beta-1a (ATC code according to WHO: L03ab13)
Closing Date31 Jul 2025
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Conclusion of non-exclusive drug discount agreements according to Section 130a Paragraph 8 SGB V by way of a so-called Oh model for Ws Golimumab (atc code according to Who: L04ab06) (172/2023-oh)
Closing Date31 Dec 2024
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient bosutinib (ATC code according to WHO: L01EA04)
Closing Date31 Dec 2025
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Degree Not Exclusive Drug discount association According to Section 130a Paragraph 8 SGB V By way of an open-house model for the active ingredient colistin (atc code according to Who: J01xb01)
Closing Date31 Jan 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient tocilizumab (ATC code according to WHO: L04AC07)
Closing Date31 Dec 2025
Tender AmountRefer Documents 
141-150 of 179 active Tenders